Perfuze

Newcastle, Ireland

Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.

$23.9M raised

Mar 2025

Venture - Series Unknown

Top Investors

Enterprise IrelandSV Health InvestorsEQT Life SciencesSeroba Life SciencesEarlyBird

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Perfuze raised?

Perfuze has raised $23.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.

Who are Perfuze's investors?

Perfuze's investors include Enterprise Ireland, SV Health Investors, EQT Life Sciences, Seroba Life Sciences, EarlyBird.

Where is Perfuze headquartered?

Perfuze is headquartered in Newcastle, Ireland.

What does Perfuze do?

Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.

What stage is Perfuze at?

Perfuze is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 13, 2025.

MLA

"Perfuze — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/perfuze. Accessed June 4, 2026.

APA

VCBacked. (2025). Perfuze — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/perfuze

Wikipedia (cite web)

{{cite web |title=Perfuze — Funding & Investors |url=https://www.vcbacked.co/company/perfuze |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 13, 2025.